The DOI matches its Crossref record; 237 of the 238 references it cites were found in a registry or an index.
Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
Open accessAbstract
Aurora kinase A (AURKA) belongs to the family of serine/threonine kinases, whose activation is necessary for cell division processes via regulation of mitosis. AURKA shows significantly higher expression in cancer tissues than in normal control tissues for multiple tumor types according to the TCGA database. Activation of AURKA has been demonstrated to play an important role in a wide range of cancers, and numerous AURKA substrates have been identified. AURKA-mediated phosphorylation can regulate the functions of AURKA substrates, some of which are mitosis regulators, tumor suppressors or oncogenes. In addition, enrichment of AURKA-interacting proteins with KEGG pathway and GO analysis have demonstrated that these proteins are involved in classic oncogenic pathways. All of this evidence favors the idea of AURKA as a target for cancer therapy, and some small molecules targeting AURKA have been discovered. These AURKA inhibitors (AKIs) have been tested in preclinical studies, and some of them have been subjected to clinical trials as monotherapies or in combination with classic chemotherapy or other targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“AURKA, a member of the AURK family member, is frequently overexpressed in a wide range of cancers and plays a critical role in oncogenesis [127, 128].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Zhou, S.-F., Ding, Y.-H., Zhou, Z.-W., Ha, C., Zhang, X.-Y., Pan, S.-T., He, Z.-X., Edelman, J. L., Wang, D., Yang, Y.-X., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s74062 · Cited by 87
RetractedZheng, X., Guo, J. P., Yang, H., Kanai, M., He, L., Li, Y., Koomen, J. M., Minton, S., Gao, M., Ren, X. B., et al. (2013) · Oncogene · doi:10.1038/onc.2013.444 · Cited by 39
RetractedZhou, S.-F., Li, J.-P., Yang, Y.-X., Liu, Q., Zhou, Z.-W., Pan, S., He, Z., Zhang, X., Yang, T., Pan, S.-Y., et al. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s74412 · Cited by 36
RetractedHarrington, E. A., Bebbington, D., Moore, J., Rasmussen, R. K., Ajose-Adeogun, A. O., Nakayama, T., Graham, J. A., Demur, C., Hercend, T., Diu-Hercend, A., et al. (2004) · Nature Medicine · doi:10.1038/nm1003 · Cited by 965
Dai, Y., Xu, C., Sun, X., & Chen, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00592f · Cited by 931
Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery
Macůrek, L., Lindqvist, A., Lim, D., Lampson, M. A., Klompmaker, R., Freire, R., Clouin, C., Taylor, S. S., Yaffe, M. B., & Medema, R. H. (2008) · Nature · doi:10.1038/nature07185 · Cited by 710
Mitotic Phosphorylation of Histone H3: Spatio-Temporal Regulation by Mammalian Aurora Kinases
Crosio, C., Fimia, G. M., Loury, R., Kimura, M., Okano, Y., Zhou, H., Sen, S., Allis, C. D., & Sassone-Corsi, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.874-885.2002 · Cited by 666
Structural Basis of Aurora-A Activation by TPX2 at the Mitotic Spindle
Bayliss, R., Sardon, T., Vernos, I., & Conti, E. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00392-7 · Cited by 636
Hirota, T., Kunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Nitta, M., Hatakeyama, K., & Saya, H. (2003) · Cell · doi:10.1016/s0092-8674(03)00642-1 · Cited by 628
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
Katayama, H., Sasai, K., Kawai, H., Yuan, Z.-M., Bondaruk, J., Suzuki, F., Fujii, S., Arlinghaus, R. B., Czerniak, B. A., & Sen, S. (2004) · Nature Genetics · doi:10.1038/ng1279 · Cited by 588
Cited by
Surface plasmon resonance technology: Recent advances, applications and experimental cases
Capelli, D., Scognamiglio, V., & Montanari, R. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117079 · Cited by 239
Clinical significance of FBXW7 loss of function in human cancers
Fan, J., Bellon, M., Ju, M., Zhao, L., Wei, M., Fu, L., & Nicot, C. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01548-2 · Cited by 168
Aurora kinase A, a synthetic lethal target for precision cancer medicine
Mou, P. K., Yang, E. J., Shi, C., Ren, G., Tao, S., & Shim, J. S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00635-6 · Cited by 156
Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer
Kúdelová, E., Smolár, M., Holubeková, V., Horňáková, A., Dvorská, D., Lučanský, V., Koklesová, L., Kúdela, E., & Kubatka, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314937 · Cited by 135
Ren, L., Yang, Y., Li, W., Zheng, X., Liu, J., Li, S., Yang, H. S., Zhang, Y., Ge, B., Zhang, S., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03641-y · Cited by 124
Metadata
- Authors
- Du, R., Huang, C., Liu, K., Li, X., & Dong, Z.
- Affiliations
- Zhengzhou University (CN)
- Corresponding author
- Du, Ruijuan
- Li, Xiang
- Dong, Zigang
- Venue
- Molecular Cancer
- Published
- 2021-01-15
- Volume
- 20
- Issue
- 1
- Pages
- 15-15
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC7809767
- OpenAlex
- W3123995258
- Cited by
- 586
- References
- 238
- Citations by year
- 2026: 71 · 2025: 118 · 2024: 145 · 2023: 124 · 2022: 100 · 2021: 26
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81802795, 82073075, 31301144)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- AURKA, AURKA inhibitors, cancer therapy, mitosis regulation, serine/threonine kinase, oncogenic signaling, small-molecule kinase inhibitors, combination chemotherapy, targeted therapy
- MeSH terms
- Animals, Humans, Neoplasms, Substrate Specificity, Survival Analysis, Protein Kinase Inhibitors, Molecular Targeted Therapy, Aurora Kinase A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. https://app.cochat.ai/papers/10.1186/s12943-020-01305-3
- The paper
- Du, R., Huang, C., Liu, K., Li, X., & Dong, Z. (2021). Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy. Molecular Cancer. https://doi.org/10.1186/s12943-020-01305-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.